Published:
Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
DENVER, July 24 /PRNewswire/ -- Pharmatech, Inc., a Research Management
Organization (RMO), has contracted with five leading pharmaceutical companies
to provide research and site management services for their clinical trials
using the Just-in-Time (JIT) enrollment strategy. The new trials include the
following disease indications: follicular Non-Hodgkin's Lymphoma, Metastatic
Breast Cancer, Metastatic Sarcoma, Chronic Myelogenous Leukemia, and Non-Small
Cell Lung Cancer (NSCLC).
Pharmatech will manage the trials using its innovative JIT approach. This
streamlined approach was created to increase enrollment in oncology clinical
trials. This patient first initiative allows for identification of cancer
patients through basic standard of care procedures, so the site opens only if
the patient qualifies for the study. Patient enrollment increases because a
protocol is rolled out to a large number of qualified Research Network sites
with minimal expense of time and capital for both the sites and sponsors.
The new oncology clinical trials are targeted to achieve enrollment of
over 500 cancer patients with the participation of approximately 165
Pharmatech Research Network sites. Matthew Wiener, Pharmatech CEO, states
that "The recent activity in new business has been a true testament to the
acceptance of the Just-In-Time enrollment strategy. Study sponsors and sites
have praised the new enrollment methodology, as cancer patients are treated in
a more efficient manner and sponsors see their trials completed in a shorter
time frame."
About Pharmatech, Inc.:
Pharmatech, headquartered inDenver, Colorado, is a Research Management
Organization (RMO) dedicated to the highest quality of clinical research.
Pharmatech provides services of a Site Management Organization (SMO) and a
Contract Research Organization (CRO) with a focus in oncology clinical trials.
Through an organized research network, the Company focuses on the development
and utilization of therapeutic products among sponsors, investigators, and
patients. For more information about Pharmatech, please visit
http://www.pharmatech.com.
Key Words: Oncology, Clinical Trials, Cancer Patients, CRO, SMO, Lymphoma,
Leukemia, Breast Cancer, Lung Cancer, Sarcoma, Just-In-Time
SOURCE Pharmatech, Inc.
Copyright © 2009, PRNewswire
Copyright © 2009, NewsBlaze,
Daily NewsTags: ,HEA,MTC,BIO,CON,TRI,CO-Pharmatech-Trials
Search News
Daily News
